Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

PPARγ is a therapeutic target that has been exploited for treatment of type II diabetes mellitus (T2DM) with agonist drugs. Since PPARγ is expressed by many hematopoietic, mesodermal and epithelial cancers, agonist drugs were tested and shown to have both preclinical and clinical anticancer activiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Jack D., Goldenberg, David M., Blumenthal, Rosalyn D.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528255/
https://www.ncbi.nlm.nih.gov/pubmed/18779871
http://dx.doi.org/10.1155/2008/494161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528255/
https://www.ncbi.nlm.nih.gov/pubmed/18779871
http://dx.doi.org/10.1155/2008/494161

Ejemplares similares